Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $31,109 | $19,128 | $35,567 | $192,956 |
| - Cash | $8,636 | $9,432 | $19,993 | $35,605 |
| + Debt | $3,664 | $2,869 | $3,544 | $5,677 |
| Enterprise Value | $26,137 | $12,565 | $19,118 | $163,028 |
| Revenue | $1,881 | $1,503 | $958 | $2,198 |
| % Growth | 25.1% | 56.9% | -56.4% | – |
| Gross Profit | $740 | $413 | -$18 | $1,420 |
| % Margin | 39.3% | 27.5% | -1.9% | 64.6% |
| EBITDA | -$59,015 | -$23,123 | -$13,309 | -$48,457 |
| % Margin | -3,137.4% | -1,538.5% | -1,389.2% | -2,204.6% |
| Net Income | -$60,663 | -$27,781 | -$72,902 | -$64,097 |
| % Margin | -3,225% | -1,848.4% | -7,609.8% | -2,916.2% |
| EPS Diluted | -4.661 | -3.75 | -20 | -14.4 |
| % Growth | -24.3% | 81.3% | -38.9% | – |
| Operating Cash Flow | -$20,713 | -$23,325 | -$45,568 | -$35,941 |
| Capital Expenditures | -$516 | -$281 | -$4,340 | -$2,247 |
| Free Cash Flow | -$21,229 | -$23,606 | -$49,908 | -$38,188 |